Public recall detail

Sanofi-Aventis Avapro Product Recall(2021-06-14)

medium
Recall Safety notice
Quick summary

Quick summary: Sanofi-Aventis Avapro Product Recall(2021-06-14) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Sanofi-Aventis Avapro Product Recall(2021-06-14) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionA. Avapro 75mg DIN, NPN, DIN-HIM DIN 02237923 Dosage form Tablet Strength Irbesartan 75 mg Lot or serial number FT00590 Companies Recalling Firm Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA Marketing Authorization Holder Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA B. Avapro 150mg DIN, NPN, DIN-HIM DIN 02237924 Dosage form Tablet Strength Irbesartan 150 mg Lot or serial number ET04153, FT01995, FT01238 Companies Recalling Firm Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA Marketing Authorization Holder Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA C. Avapro 300mg DIN, NPN, DIN-HIM DIN 02237925 Dosage form Tablet Strength Irbesartan 300 mg Lot or serial number FT00969, FT01225, FT01226, FT01999, FT04262 Companies Recalling Firm Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA Marketing Authorization Holder Sanofi-Aventis Canada Inc. 2905 Place Louis.R-Renaud Laval H7V 0A3 Quebec CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...